Diagnosing neurotransmitter disruptions involves a combination of clinical evaluation, patient history, and laboratory tests. Blood or urine tests can sometimes identify specific toxins or their metabolites. Neuroimaging and EEG can be useful in assessing the functional state of the nervous system. In some cases, cerebrospinal fluid analysis may be required to directly measure neurotransmitter levels.
